Esperion Therapeutics, Inc. (ESPR) was a big mover last session, as its shares rose over 14% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. Yesterday’s rally continues the uptrend for the company since Aug 6, as the stock is now up almost 9%.
Over the last 30 days, the company witnessed two positive estimate revisions and the Zacks Consensus Estimate also moved higher, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can turn into more strength down the road.
Esperion Therapeutics currently has a Zacks Rank #2 (Buy).
Another favorably-ranked med-drugs stock is Valeant Pharmaceuticals International (VRX) with a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
ESPERION THERAP (ESPR): Free Stock Analysis Report
VALEANT PHARMA (VRX): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research